SCHEMBL25857086

CCC(C)(C)CCC(=O)NCC(C)(C)COCC(C)(C)CC(=O)NCC(C)(CC)COCC(C)(C)CNC(=O)CC[C@H](NC(=O)CC(C)(C)COCCNC(=O)CCN1C(=O)C=CC1=O)C(=O)NCC(C)(CC)COCC(C)(C)CC(=O)NCC(C)(C)COCCNC(=O)C(C)(C)CCC(C)(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL27382245	0.84	GLP1R (0.34)	—
SCHEMBL25840353	0.80	GLP1R (0.42)	—
SCHEMBL26259231	0.80	AKT1 (0.37)	—
SCHEMBL25845185	0.80	AKT1 (0.35)	—
SCHEMBL27382530	0.79	GLP1R (0.43)	—
SCHEMBL25840066	0.77	—	—
SCHEMBL25840047	0.77	—	—
SCHEMBL25839932	0.77	—	—
SCHEMBL25839941	0.77	—	—
SCHEMBL25839886	0.75	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230226193-A1	LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS	Arrowhead Pharmaceuticals, Inc.	2023-07-20	—	—	US	disclosed